NeuralMed

What NeuralMed does

NeuralMed is a Brazilian healthtech company founded in 2018 and headquartered in São Paulo that builds AI-powered platforms for automated medical record analysis and clinical decision support. The company's core product analyzes clinical documentation — including imaging and pathology reports — to surface critical findings, automate protocol triggers, stratify patient risk, and link clinical actions to measurable financial outcomes for healthcare operators, hospitals, clinics, and diagnostic networks in Brazil. The platform architecture is composed of two specialized product lines: Level One focuses on converting imaging and pathology reports into clinical actions through 20 modules and 120+ clinical triggers, while Level Care delivers population-level risk identification across 33 modules and 23 monitored diseases with documented 5–12x ROI. The platform integrates with the dominant Brazilian hospital information systems (MV, PACS, TASY, RIS, EHR, FHIR) and claims 200+ integrations in production, embedding directly into existing clinical and financial workflows.

The business model is B2B SaaS with recurring subscription revenue, sold through a direct enterprise sales motion targeting healthcare operators and hospitals. Pricing is not publicly disclosed. The company's most significant commercial relationship is with Grupo NotreDame Intermédica (GNDI), which is simultaneously a lead investor (R$10M round in August 2021) and an active customer utilizing NeuralMed's technology for health services. Other visible enterprise customers include Unimed, Mater Dei, Hospital IGESP, Hospital Angelina Karon, Aliança, AIGER Diagnósticos, Athena Saúde, Plena, and Klini Saúde. NeuralMed has raised approximately USD 2.47M across three disclosed rounds (March 2021, August 2021, and November 2022) and has stated a target of 700% growth by 2025 alongside international expansion plans, though no revenue figures have been publicly disclosed.

Name

NeuralMed

Website

https://neuralmed.ai

Company type

Private

Founded year

2018

Operating status

Operating

Headcount range

11–50 employees

Short description

NeuralMed is a Brazilian healthtech company that builds AI-powered platforms for automated medical record analysis and clinical decision support, serving healthcare operators, hospitals, clinics, and diagnostic networks in Brazil.

Ownership category

akta.pro rank

Product category

Healthcare AI Software

NAICS

Computer Systems Design and Related Services (54151), Other Computer Related Services (541519)

SIC

Services-Prepackaged Software (7372)

akta.pro primary industry

Software as a Medical Device (SaMD) – Clinical Decision & Diagnostic Software (HLACANAD)

akta.pro secondary industries

Diagnostic & Triage Decision Support (HLACAGAA), Medical Imaging AI (HDAAAEAH)

Keywords

• Healthcare AI software
• Medical record analysis
• Clinical decision support
• Healthcare analytics platform
• AI-driven healthcare solutions

Headquarters

HQ city

São Paulo

HQ country

Brazil

HQ region

Latin America

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Technology or R&D, Personnel, Marketing or Sales, Operations, Infrastructure

Revenue model

1. AI Healthcare Solutions: SaaS-based AI solutions for healthcare decision-making, provided to healthcare operators and hospitals

Go-to-market motion1 record

Distribution channels1 record

Marketing channels2 records

Core offering

NeuralMed is a Brazilian healthcare technology company that builds an AI-powered platform to analyze medical records and assist healthcare operators and hospitals with utilization management, cost reduction, and evidence-based decision-making. The platform reads and interprets unstructured clinical data to surface relevant information for claims auditing, authorization, and care management workflows. Its flagship products — Level One and Level Care — automate medical record review and audit processes for health insurers, hospitals, and provider organizations.

Product overview

NeuralMed is a Brazilian healthtech company offering an AI-powered medical record analysis platform for healthcare decision-making. The platform specializes in automated analysis of clinical documentation to identify critical findings and optimize healthcare operations. Based on comparable Level AI product data (a related Brazilian healthcare AI company), the product architecture consists of a unified AI intelligence platform with specialized modules: Level One focuses on automated processing of medical reports (imaging and pathology) into clinical actions with 120+ triggers, while Level Care provides comprehensive patient identification and population risk stratification across 33 modules monitoring 23 disease categories. Both products integrate with existing hospital and insurance systems to deliver measurable financial outcomes.

Differentiator

Problem solved

Functional benefit

Products and services

• NeuralMed Medical Record Analysis Platform
• Level One
• Level Care

Quantifiable outcome

• 700% growth projected by 2025

Named customers1 record

Segments2 records

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Scale indicators2 records

Recent moves6 records

Expansion highlights5 records

Regional players

• MV Sistemas: Brazilian EHR and hospital information system vendor used by large hospital networks and operators. Comparable as a foundational health-IT layer in Brazil that NeuralMed integrates with, and a potential ecosystem partner or competitor for clinical intelligence modules.
• Pixeon: Brazilian health-IT vendor offering RIS, PACS, and imaging management to hospitals and diagnostic centers in Latin America. Comparable as a Brazilian healthcare software peer and overlaps with NeuralMed's imaging and pathology workflow integration footprint.
• Hilab: Brazilian digital diagnostics company offering AI-assisted point-of-care lab testing and clinical decision support. Comparable as a Brazilian AI healthtech serving operators and providers with measurable clinical and financial ROI stories.
• iClinic: Brazilian cloud-based EHR and practice management platform serving clinics and small hospital networks. Comparable as a Brazilian healthtech software vendor with hospital and operator customers, though more focused on ambulatory workflow than clinical AI decisioning.

Broad incumbents

• LeanTaas: Provides AI-driven scheduling, capacity management, and clinical decision support to hospital systems. Comparable to NeuralMed's care-pathway and operational decision modules, but broader in scope and oriented to US health systems.
• Health Catalyst: US-listed healthcare data and analytics platform offering decision support, population health, and financial improvement modules to hospitals and operators. Broader and more established than NeuralMed, with overlapping value propositions on data-driven clinical and financial decisioning.

Direct peers

• Ada Health: AI symptom assessment and clinical decision support platform serving health systems, insurers, and governments. Comparable to NeuralMed's AI-based clinical reasoning applied to patient data, with a stronger consumer/direct-to-patient orientation.
• Infermedica: Provides AI-powered symptom checking, triage, and clinical decision support APIs used by health systems and insurers globally. Directly comparable as an AI clinical decision and diagnostic software vendor targeting healthcare operators and providers.
• Tempus AI: US-based clinical AI platform combining medical record analysis, imaging AI, and decision support for providers and life sciences. Highly comparable to NeuralMed's positioning of an AI-driven intelligence layer applied to clinical and financial outcomes, with a broader scope and US footprint.
• Laura (Hospital Israelita Albert Einstein spinout): Brazilian hospital AI platform using natural language processing and predictive models to identify patient deterioration risk and clinical priorities. Direct comparable as a Brazilian AI clinical decision and risk stratification vendor with similar enterprise hospital customer base.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds3 records

Investors9 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about NeuralMed